Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2019-03-08, Stock:JNJ, The news for the past five days is as follows:
2019-03-01: NEWS1: 10 Best Stocks to Buy and Hold Forever.NEWS2: 10 Best Stocks to Buy and Hold Forever.NEWS3: Top Stock Reports for Facebook, Johnson & Johnson & JPMorgan.NEWS4: Top Stock Reports for Facebook, Johnson & Johnson & JPMorgan.NEWS5: MTUM, JNJ, LLY, KO: ETF Inflow Alert.NEWS6: MTUM, JNJ, LLY, KO: ETF Inflow Alert.NEWS7: Top Stock Reports for Facebook, Johnson & Johnson & JPMorgan.NEWS8: Pharma Stock Roundup: Roche to Buy ONCE, Lawmakers Grill CEOs Over High Drug Prices.NEWS9: Pharma Stock Roundup: Roche to Buy ONCE, Lawmakers Grill CEOs Over High Drug Prices.NEWS10: Health Care Sector Update for 03/01/2019: IMGN, MRSN, PBYI, JNJ, PFE, MRK, ABT, AMGN.NEWS11: Health Care Sector Update for 03/01/2019: IMGN, MRSN, PBYI, JNJ, PFE, MRK, ABT, AMGN.NEWS12: Pharma Stock Roundup: Roche to Buy ONCE, Lawmakers Grill CEOs Over High Drug Prices.NEWS13: Novartis AG (NVS) Ex-Dividend Date Scheduled for March 04, 2019.NEWS14: Novartis AG (NVS) Ex-Dividend Date Scheduled for March 04, 2019.NEWS15: Johnson & Johnson (NYSE:JNJ): Immense Growth Potential?.NEWS16: Morning News Call - India, March 1.
2019-03-04: NEWS1: Pacira (PCRX) Q4 Earnings and Revenues Surpass Estimates.NEWS2: Pacira (PCRX) Q4 Earnings and Revenues Surpass Estimates.NEWS3: The Zacks Analyst Blog Highlights: Facebook, Johnson & Johnson, JPMorgan, Sun Life and Evergy.NEWS4: The Zacks Analyst Blog Highlights: Facebook, Johnson & Johnson, JPMorgan, Sun Life and Evergy.NEWS5: Why NOW Is the Time to Buy Gene Therapy Stocks.NEWS6: The Zacks Analyst Blog Highlights: Facebook, Johnson & Johnson, JPMorgan, Sun Life and Evergy.NEWS7: Pacira (PCRX) Q4 Earnings and Revenues Surpass Estimates.NEWS8: Health Care Sector Update for 03/04/2019: NITE, BIIB, ASND, AVXL, JNJ, PFE, MRK, ABT, AMGN.NEWS9: Health Care Sector Update for 03/04/2019: NITE, BIIB, ASND, AVXL, JNJ, PFE, MRK, ABT, AMGN.NEWS10: Phibro Animal Health Corporation (PAHC) Ex-Dividend Date Scheduled for March 05, 2019.NEWS11: Phibro Animal Health Corporation (PAHC) Ex-Dividend Date Scheduled for March 05, 2019.NEWS12: This Is Why TG Therapeutics Stock Soared 65.9% in February.NEWS13: This Is Why TG Therapeutics Stock Soared 65.9% in February.NEWS14: The 3 Oldest Members of Biotech's Billion-Burned Club.NEWS15: The 3 Oldest Members of Biotech's Billion-Burned Club.NEWS16: The 3 Oldest Members of Biotech&apos;s Billion-Burned Club.
2019-03-05: NEWS1: Why Geron Skyrocketed 27% in February.NEWS2: Why Geron Skyrocketed 27% in February.NEWS3: This ETF Holds Stocks Insiders Want to Own.NEWS4: This ETF Holds Stocks Insiders Want to Own.NEWS5: See inside Johnson & Johnson's new $18M Lake Nona facility (PHOTOS).NEWS6: Health Care Sector Update for 03/05/2019: ADMS, NNVC, NVTA, JNJ, PFE, MRK, ABT, AMGN.NEWS7: Health Care Sector Update for 03/05/2019: ADMS, NNVC, NVTA, JNJ, PFE, MRK, ABT, AMGN.NEWS8: Why Geron Skyrocketed 27% in February.NEWS9: The Daily Biotech Pulse: Novartis Psoriasis Drug Found Superior, Ascendis Offering, Adamas Earnings.
2019-03-06: NEWS1: Can Smart Beta & Factor ETFs Beat the Market?.NEWS2: Can Smart Beta & Factor ETFs Beat the Market?.NEWS3: Notable Wednesday Option Activity: JNJ, TPX, IR.NEWS4: Notable Wednesday Option Activity: JNJ, TPX, IR.NEWS5: Can Smart Beta & Factor ETFs Beat the Market?.NEWS6: FDA Commissioner Gottlieb resigns.NEWS7: Dow Falls as Investors Eye Details From Trade Talks, Oil Prices Tumble.NEWS8: J&J prices ketamine-like depression treatment at $590-$885 for two doses.NEWS9: Jim Cramer on Why Johnson & Johnson's Anti-Depressant Is Important.NEWS10: J&J prices ketamine-like depression treatment at $590-$885 for two doses.NEWS11: Ketamine-Like Depression Drug Isn’t a Surefire Hit.NEWS12: U.S. FDA finds asbestos in three Claire's cosmetics products.NEWS13: The Late Morning Rundown: March 06, 2019.NEWS14: Johnson & Johnson Edges Higher After FDA Approves Nasal Spray Antidepressant.NEWS15: Can Gilead Sciences Return to Winning Ways?.NEWS16: J&J's (JNJ) Nasal Spray Spravato Gets FDA Nod for Depression.NEWS17: J&J's (JNJ) Nasal Spray Spravato Gets FDA Nod for Depression.NEWS18: Jim Cramer Keeping an Eye on Dollar Tree, GE and Johnson & Johnson.NEWS19: Dow Turns Lower as Investors Eye Details From Trade Talks.NEWS20: Jim Cramer: What to Watch from GE, Johnson & Johnson and Dollar Tree.NEWS21: Health Care Sector Update for 03/06/2019: VLRX, OPTN, INFI, JNJ, PFE, MRK, ABT, AMGN.NEWS22: Health Care Sector Update for 03/06/2019: VLRX, OPTN, INFI, JNJ, PFE, MRK, ABT, AMGN.NEWS23: Stocks Fade Ahead Of Fed Data; This Dow Jones Stock Gets FDA Boost.NEWS24: Stocks Open Mixed; This Dow Jones Stock Gets FDA Boost.NEWS25: Dow Edges Higher but Wall Street Is Mixed as Investors Eye Trade Talks.NEWS26: FDA Approves Major Novel Depression Drug For First Time In 3 Decades.NEWS27: J&J's (JNJ) Nasal Spray Spravato Gets FDA Nod for Depression.NEWS28: Stock Futures Ease; This Dow Jones Stock Gets FDA Boost.NEWS29: Stocks making the biggest moves premarket: General Electric, BJ's Wholesale, TripAdvisor & more.NEWS30: Johnson & Johnson, General Electric, NIO, Abercrombie - 5 Things You Must Know.NEWS31: The Daily Biotech Pulse: Horizon Pharma Under DoJ Radar, FDA Greenlights J&J's Depression Drug, Endologix Reverse Split.NEWS32: Market Morning: FDA Head Resigns, India Strikes Out, Special K Approved, Trade Deficit Explodes.NEWS33: Stocks - GE Slides in Premarket, Abercrombie and Fitch, Dollar Tree Soar.NEWS34: FDA allows treatment of depression with club drug's cousin.NEWS35: FDA allows treatment of depression with club drug's cousin.NEWS36: [$$] FDA Approves Controversial Drug for Depression.NEWS37: [$$] US approves first depression drug in decades.NEWS38: J&J nasal spray gets U.S. approval as first new type of anti-depressant in decades.NEWS39: Mind-altering, ketamine-like drug OK'd for severe depression.NEWS40: FDA approves J&J's ketamine-like nasal spray for depression.NEWS41: FDA approves Johnson & Johnson’s ketamine-like drug to treat severe depression.NEWS42: FDA approves J&J's ketamine-like nasal spray for depression.NEWS43: Trippy ketamine-like drug approved for severe depression.
2019-03-07: NEWS1: Why News From J&J, Allergan Could Be A Boon For This Biotech Stock.NEWS2: Monthly shots control HIV as well as pills in 2 big studies.NEWS3: Monthly shots control HIV as well as pills in 2 big studies.NEWS4: Allergan's Depression Candidate Fails in Studies, Stock Down.NEWS5: Allergan's Depression Candidate Fails in Studies, Stock Down.NEWS6: Take Profits Now and Buy Shopify Stock on Its Next Big Dip.NEWS7: Allergan's Depression Drug Letdown Largely Expected: Analysts Focus On Remainder Of Pipeline.NEWS8: Allergan Rises After FDA Accepts License Applications for Botox Supplements.NEWS9: Health Care Sector Update for 03/07/2019: GTXI, BPTH, CODX, JNJ, PFE, ABT, MRK, AMGN.NEWS10: Health Care Sector Update for 03/07/2019: GTXI, BPTH, CODX, JNJ, PFE, ABT, MRK, AMGN.NEWS11: Allergan Recovers After Depression Treatment Candidate Fails Study.NEWS12: Allergan's Depression Candidate Fails in Studies, Stock Down.NEWS13: Allergan Falls After Depression Treatment Candidate Fails Study.NEWS14: 2 Biotech Stocks With Major Incoming Catalysts.NEWS15: 2 Biotech Stocks With Major Incoming Catalysts.NEWS16: 2 Biotech Stocks With Major Incoming Catalysts.

Answer: Decrease